TARA BALDWIN: Open Payments
NPI 1801544796 · MONROE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,760 in 89 payments from 16 companies in 2025. Trend: 2023 $1,043 · 2024 $1,249 · 2025 $1,760
Food & beverage: $1,760
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $442 |
| Janssen Biotech, Inc. | 18 | $351 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $226 |
| Madrigal Pharmaceuticals | 7 | $168 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $140 |
| GENZYME CORPORATION | 3 | $75 |
| Intercept Pharmaceuticals, Inc. | 3 | $73 |
| Ardelyx, Inc. | 4 | $67 |
| Lilly USA, LLC | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
Products named: TREMFYA, ENTYVIO, REZDIFFRA, SKYRIZI, RINVOQ, XIFAXAN, DUPIXENT, OCALIVA.
Industry payments across MI — which companies pay providers there.
